Journal of Ocular Pharmacology and Therapeutics Peer-Reviewed Journal Publishes NB2222 Ocular Bioavailability Data LONG BEACH, CA, June 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Emerald Bioscience, Inc. (EMBI), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today announced that newly published scientific data highlight… Read More..

Adds Insurtech Solutions to Rokk3r Platform Miami, FL, June 04, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Rokk3r Inc. (OTC Pink: ROKK) (“Rokk3r”), a global idea-to-exit consulting services company that leverages exponential technologies to generate value, today announced its acquisition of Bullfrog Ventures (“Bullfrog”), an incubator specializing in insurance and… Read More..

We are pleased to share a poster presentation made at the 2019 ASCO Annual Meeting. This presentation contains work by Northwestern University clinicians and scientists demonstrating biodistribution and tolerability data from a Phase 0 first-in-human study of NU-0129, a gold-based SNA targeting the Bcl2L12 gene. The study was conducted in… Read More..